Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Recurrent Uterine Corpus Sarcoma × Epothilones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Breast Neoplasms 2 Recurrent Uterine Corpus Sarcoma 1 Endometrial Adenocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Bilateral Breast Carcinoma 1

Interventions

pazopanib 1 ixabepilone 1 Thalidomide 1 Gemcitabine 1 Epothilones 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01168232 2019-08-08

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

National Cancer Institute (NCI)

Phase 2 Completed

42 enrolled 10 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡